Concentration-QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia
Pharmacometrician, Hannah Huang, presents “Population Pharmacokinetic and Concentration-QTc Analysis of Quizartinib in Patients With FLT3-ITD–Positive Relapsed/Refractory Acute Myeloid Leukemia.”
- Development of PopPK models for quizartinib and its major metabolite (AC886) in a pooled analysis of 7 trials
- Patient characteristics
- C-QTc Analysis
- and more!
Presented at SLP MIDD+ Virtual Conference March 3-4, 2021